مشخصات کتاب

Pharmacoepidemiology, Fifth Edition

ویرایش:  
 
سری:  
ISBN (شابک) : 9780470654750, 9781119959946 
ناشر: Wiley-Blackwell 
سال نشر: 2012 
تعداد صفحات: 965 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 7 مگابایت 

در صورت تبدیل فایل کتاب Pharmacoepidemiology, Fifth Edition به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب فارماکوپیدمیولوژی، ویرایش پنجم نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.

توضیحاتی درمورد کتاب به خارجی

Now in its fifth edition, Pharmacoepidemiology defines the discipline and provides the most comprehensive guidance of any book on the topic. Written by world renowned experts in the field, this valuable text surveys the research designs and sources of data available for pharmacoepidemiologic research, and provides descriptions of various automated data systems, along with the advantages and disadvantages of each.  Incorporating perspectives from academia, industry and regulatory agencies, this book provides detailed insights into all aspects of pharmacoepidemiology.Content:
Chapter 1 What is Pharmacoepidemiology? (pages 1–22): Brian L. Strom
Chapter 2 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies (pages 23–37): Jeffrey S. Barrett and Athena F. Zuppa
Chapter 3 Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies (pages 38–51): Brian L. Strom
Chapter 4 Sample Size Considerations for Pharmacoepidemiologic Studies (pages 52–61): Brian L. Strom
Chapter 5 When Should One Perform Pharmacoepidemiologic Studies? (pages 62–70): Brian L. Strom
Chapter 6 The Role of Pharmacoepidemiology in the Health?Care System and Academia (pages 71–83): Jerry Avorn
Chapter 7 The Role of Pharmacoepidemiology in Industry (pages 84–106): Jingping Mo, Nicolle M. Gatto, Rachel E. Sobel and Robert F. Reynolds
Chapter 8 The Role of Pharmacoepidemiology in Regulatory Agencies (pages 107–116): Gerald J. Dal Pan and Peter Arlett
Chapter 9 Pharmacoepidemiology and the Law (pages 117–134): Aaron S. Kesselheim
Chapter 10 Postmarketing Spontaneous Pharmacovigilance Reporting Systems (pages 135–157): Gerald J. Dal Pan, Marie Lindquist and Kate Gelperin
Chapter 11 Overview of Automated Databases in Pharmacoepidemiology (pages 158–162): Brian L. Strom
Chapter 12 Health Maintenance Organizations/Health Plans (pages 163–188): Susan E. Andrade, Marsha A. Raebel, Denise Boudreau, Robert L. Davis, Katherine Haffenreffer, Pamala A. Pawloski, Sengwee Toh and Richard Platt
Chapter 13 Commercial Insurance Databases (pages 189–208): John Seeger and Gregory W. Daniel
Chapter 14 US Government Claims Databases (pages 209–223): Sean Hennessy, Cristin Palumbo Freeman and Francesca Cunningham
Chapter 15 Medical Record Databases (pages 224–243): Alexis Ogdie, Sinead M. Langan, John Parkinson, Hassy Dattani, Karel Kostev and Joel M. Gelfand
Chapter 16 In?Hospital Databases (pages 244–258): Brian T. Fisher, Peter K. Lindenauer and Chris Feudtner
Chapter 17 Canadian Provincial Databases (pages 259–269): Yola Moride and Colleen J. Metge
Chapter 18 Pharmacy?Based Medical Record Linkage Systems (pages 270–286): Ron M. C. Herings and Lars Pedersen
Chapter 19 Case–Control Surveillance (pages 287–300): Lynn Rosenberg, Patricia F. Coogan and Julie R. Palmer
Chapter 20 Prescription–Event Monitoring (pages 301–330): Deborah Layton and Saad A. W. Shakir
Chapter 21 Registries (pages 331–346): Nancy A. Dreyer and Priscilla Velentgas
Chapter 22 Field Studies (pages 347–363): David W. Kaufman
Chapter 23 How Should One Perform Pharmacoepidemiologic Studies? Choosing among the Available Alternatives (pages 364–376): Brian L. Strom
Chapter 24 Studies of Drug Utilization (pages 377–401): David Lee and Ulf Bergman
Chapter 25 Evaluating and Improving Physician Prescribing (pages 402–422): Sumit R. Majumdar, Helene Levens Lipton and Stephen B. Soumerai
Chapter 26 Pharmacoepidemiologic Studies of Vaccine Safety (pages 423–468): Robert T. Chen, Jason M. Glanz and Claudia Vellozzi
Chapter 27 Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices (pages 469–486): Danica Marinac?Dabic, Sharon?Lise Normand, Art Sedrakyan and Thomas Gross
Chapter 28 Studies of Drug?Induced Birth Defects (pages 487–504): Allen A. Mitchell
Chapter 29 Risk Management (pages 505–533): Gerald J. Dal Pan, Stella Blackburn and Claudia Karwoski
Chapter 30 FDA's Sentinel Initiative: Active Surveillance to Identify Safety Signals (pages 534–554): Judith A. Racoosin, Melissa A. Robb, Rachel E. Sherman and Janet Woodcock
Chapter 31 Pharmacoepidemiology and Pharmaceutical Reimbursement Policy (pages 555–560): Mitchell Levine and Jacques Lelorier
Chapter 32 Comparative Effectiveness Research (pages 561–579): Brian L. Strom, Rita Schinnar and Sean Hennessy
Chapter 33 Assessing Causality of Case Reports of Suspected Adverse Events (pages 581–600): Judith K. Jones
Chapter 34 Molecular Pharmacoepidemiology (pages 601–622): Stephen E. Kimmel, Hubert G. Leufkens and Timothy R. Rebbeck
Chapter 35 Bioethical Issues in Pharmacoepidemiologic Research (pages 623–639): Antoine C. El Khoury, Jason Karlawish, Elizabeth Andrews and Arthur Caplan
Chapter 36 The Use of Randomized Controlled Trials for Pharmacoepidemiologic Studies (pages 640–654): Samuel M. Lesko and Allen A. Mitchell
Chapter 37 The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (pages 655–677): Brian L. Strom and Kenneth L. Melmon
Chapter 38 Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (pages 678–708): Kevin A. Schulman, Henry A. Glick, Daniel Polsky and Shelby D. Reed
Chapter 39 Using Quality?of?Life Measurements in Pharmacoepidemiologic Research (pages 709–722): Holger Schunemann, Bradley C. Johnston, Roman Jaeschke and Gordon H. Guyatt
Chapter 40 The Use of Meta?analysis in Pharmacoepidemiology (pages 723–756): Jesse A. Berlin, Soledad Cepeda and Carin J. Kim
Chapter 41 Validity of Pharmacoepidemiologic Drug and Diagnosis Data (pages 757–794): Suzanne L. West, Mary Elizabeth Ritchey and Charles Poole
Chapter 42 Studies of Medication Adherence (pages 795–809): Trisha Acri and Robert Gross
Chapter 43 Risk Evaluation and Communication (pages 810–826): Susan J. Blalock and Betsy L. Sleath
Chapter 44 Studying Effects of Antibiotics (pages 827–839): Darren R. Linkin and Ebbing Lautenbach
Chapter 45 The Pharmacoepidemiology of Medication Errors (pages 840–851): Hanna M. Seidling and David W. Bates
Chapter 46 Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance (pages 852–867): Martin Kulldorff
Chapter 47 Advanced Approaches to Controlling Confounding in Pharmacoepidemiologic Studies (pages 868–891): Sebastian Schneeweiss and Samy Suissa
Chapter 48 The Future of Pharmacoepidemiology (pages 893–903): Brian L. Strom, Stephen E. Kimmel and Sean Hennessy

نظرات کاربران

کتاب های تصادفی

دانلود کتاب The Lab: Creativity and Culture

دانلود کتاب Baubegleitender Bodenschutz auf Baustellen: Schnelleinstieg für Architekten und Bauingenieure

دانلود کتاب México izquierdo: Claroscuros de las izquierdas mexicanas (1968-2021)

دانلود کتاب Advances in Artificial Intelligence: 10th Mexican International Conference on Artificial Intelligence, MICAI 2011, Puebla, Mexico, November 26 - December 4, 2011, Proceedings, Part I

دانلود کتاب Il conte di Montecristo